Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anti-inflammatory agent 22 (compound 14a) is a potent orally active compound with anti-inflammatory properties. It effectively inhibits the production of TNF-α induced by LPS, exhibiting an IC50 value of 14.6 μM. Additionally, Anti-inflammatory agent 22 has demonstrated its ability to prevent adipogenesis and effectively suppress limb lymphedema volume in mice. This compound holds promise for the treatment of inflammation-related conditions, particularly lymphedematous tissue disorders [1].
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 491,500 |
50 mg | 約6-8 週間 | ¥ 639,500 |
100 mg | 約6-8 週間 | ¥ 808,000 |
説明 | Anti-inflammatory agent 22 (compound 14a) is a potent orally active compound with anti-inflammatory properties. It effectively inhibits the production of TNF-α induced by LPS, exhibiting an IC50 value of 14.6 μM. Additionally, Anti-inflammatory agent 22 has demonstrated its ability to prevent adipogenesis and effectively suppress limb lymphedema volume in mice. This compound holds promise for the treatment of inflammation-related conditions, particularly lymphedematous tissue disorders [1]. |
分子量 | 376.36 |
分子式 | C22H16O6 |
CAS No. | 2721484-76-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anti-inflammatory agent 22 2721484-76-8 Inhibitor inhibitor inhibit